{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["C. sanguinolenta", "In vitro activity", "L. camara", "M. smegmatis", "M. tuberculosis", "Medicinal plants", "Minimum inhibitory concentration", "Resazurin microtiter assay", "Z. leprieurii"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35284659", "DateRevised": {"Year": "2022", "Month": "03", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "03", "Day": "03"}], "Language": ["eng"], "ELocationID": ["100307", "10.1016/j.jctube.2022.100307"], "Journal": {"ISSN": "2405-5794", "JournalIssue": {"Volume": "27", "PubDate": {"Year": "2022", "Month": "May"}}, "Title": "Journal of clinical tuberculosis and other mycobacterial diseases", "ISOAbbreviation": "J Clin Tuberc Other Mycobact Dis"}, "ArticleTitle": "<i>In vitro</i> antimycobacterial activity of medicinal plants <i>Lantana camara</i>, <i>Cryptolepis sanguinolenta</i>, and <i>Zanthoxylum leprieurii</i>.", "Pagination": {"StartPage": "100307", "MedlinePgn": "100307"}, "Abstract": {"AbstractText": ["Imperative need exists to search for new anti-TB drugs that are safer, and more effective against drug-resistant strains. Medicinal plants have been the source of active ingredients for drug development. However, the slow growth and biosafety level requirements of <i>M. tuberculosis</i> culture are considerable challenges. <i>M. smegmatis</i> can be used as a surrogate for <i>M. tuberculosis.</i> In the current study, preliminary phytochemical screening and antimycobacterial activity evaluation of crude methanolic extracts of medicinal plants against <i>M</i>. <i>smegmatis</i>, and two <i>M. tuberculosis</i> strains, were conducted.", "Crude methanolic extracts, obtained from the leaves of <i>L. camara</i>, roots of <i>C. sanguinolenta,</i> and stem barks of <i>Z. leprieurii</i>, were tested for antimycobacterial activity against <i>M. smegmatis</i> (mc<sup>2</sup>155), pan-sensitive (H37Rv), and rifampicin-resistant (TMC-331) <i>M. tuberculosis</i>, using visual Resazurin Microtiter Assay (REMA) on 96 well plates. Preliminary qualitative phytochemical screening tests were performed using standard chemical methods.", "The three methanolic extracts inhibited mycobacterial growth in vitro. They were more active against rifampicin-resistant strain with MICs of 176, 97, and 45\u00a0\u00b5g/mL for <i>L. camara</i>, <i>C. sanguinolenta</i>, and <i>Z. leprieurii</i> extracts, respectively. The lowest activity was observed against <i>M. smegmatis</i> with MICs of 574, 325, and 520\u00a0\u00b5g/mL, respectively. Against H37Rv, activity was intermediate to those of TMC-331 and mc<sup>2</sup>155. However, <i>L. camara</i> extract showed the same activity against H37Rv and <i>M. smegmatis</i>. Preliminary phytochemical analysis revealed alkaloids, flavonoids, phenolic compounds, saponins, tannins, and terpenoids.", "Leaves of <i>L. camara</i>, roots of <i>C. sanguinolenta</i>, and stem barks of <i>Z. leprieurii</i> exhibit antimycobacterial activity against <i>M. smegmatis</i>, pan-sensitive, and rifampicin-resistant <i>M. tuberculosis</i>. This offers the possibilities for novel therapeutic opportunities against TB including multidrug-resistant TB. Further investigations on safety and mechanisms of action are required. These studies could be done using <i>M. smegmatis</i> as a surrogate for the highly pathogenic <i>M. tuberculosis</i>."], "CopyrightInformation": "\u00a9 2022 The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharm-BioTechnology and Traditional Medicine Centre (PHARMBIOTRAC), Department of Pharmacy, Mbarara University of Science & Technology, P. O. Box 1410, Mbarara, Uganda."}, {"Identifier": [], "Affiliation": "School of Nursing and Midwifery, College of Medicine and Health Sciences, University of Rwanda, KG11 Ave, 47St/P.O. Box 3286, Kigali, Rwanda."}], "LastName": "Tuyiringire", "ForeName": "Naasson", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Applied Health Sciences, Clarke International University, P.O. Box 7782, Kampala, Uganda."}], "LastName": "Taremwa Mugisha", "ForeName": "Ivan", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Mbarara University of Science and Technology, P. O. Box 1410, Mbarara, Uganda."}], "LastName": "Tusubira", "ForeName": "Deusdedit", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Science, College of Science and Technology, University of Rwanda, KN 67 Street Nyarugenge, P.O. Box 3900, Kigali, Rwanda."}], "LastName": "Munyampundu", "ForeName": "Jean-Pierre", "Initials": "JP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Medicine and Health Sciences, University of Rwanda, KG11 Ave, 47St/P.O. Box 3286, Kigali, Rwanda."}], "LastName": "Mambo Muvunyi", "ForeName": "Claude", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Analytical Chemistry, Applied Chemometrics and Molecular Modelling, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, B-1090 Brussels, Belgium."}], "LastName": "Vander Heyden", "ForeName": "Yvan", "Initials": "Y"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Clin Tuberc Other Mycobact Dis", "NlmUniqueID": "101682877", "ISSNLinking": "2405-5794"}, "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "World Health Organization. Global tuberculosis report 2019. Geneva: 2019. https://doi.org/https://apps.who.int/iris/handle/10665/329368."}, {"Citation": "Torfs E., Piller T., Cos P., Cappoen D. Opportunities for overcoming mycobacterium tuberculosis drug resistance: Emerging mycobacterial targets and host-directed therapy. Int J Mol Sci. 2019;20:2868. doi: 10.3390/ijms20122868.", "ArticleIdList": ["10.3390/ijms20122868", "PMC6627145", "31212777"]}, {"Citation": "G. Delogu M. Sali G. Fadda The biology of mycobacterium tuberculosis infection Mediterr J Hematol Infect Dis 5 1 2013 e2013070 10.4084/mjhid.2013.070.", "ArticleIdList": ["PMC3867229", "24363885"]}, {"Citation": "Kaufmann, S.H.E.; Hahn H. Mycobacteria and TB. Issues in Infectious Diseases, Vol 2. Basel, Karger; 2003. https://doi.org/doi: 10.1159/000066884."}, {"Citation": "Ehrt S., Warner D.F., Arlehamn C.S.L., Lewinsohn D., Sette A., Walzl G., et al. Mycobacterium Tuberculosis Metabolism and Host Interaction : Mysteries and Paradoxes and Host Interaction : Mysteries. Curr Top Microbiol Immunol. 2013;374:163\u2013188. doi: 10.1007/82_2012_299.", "ArticleIdList": ["10.1007/82_2012_299", "23242856"]}, {"Citation": "P.P. Salvatore Y. Zhang Tuberculosis: Molecular Basis of Pathogenesis 2017 Elsevier Inc. New York 10.1016/B978-0-12-801238-3.95697-6."}, {"Citation": "Gygli S.M., Borrell S., Trauner A., Gagneux S. Antimicrobial resistance in Mycobacterium tuberculosis: Mechanistic and evolutionary perspectives. FEMS Microbiol Rev. 2017;41:354\u2013373. doi: 10.1093/femsre/fux011.", "ArticleIdList": ["10.1093/femsre/fux011", "28369307"]}, {"Citation": "Vilari\u00e7a A.S., Diogo N., Andr\u00e9 M., Pina J. Adverse reactions to antituberculosis drugs in in-hospital patients: Severity and risk factors. Rev Port Pneumol. 2010;16:431\u2013451. doi: 10.1016/S0873-2159(15)30040-4.", "ArticleIdList": ["10.1016/S0873-2159(15)30040-4", "20635058"]}, {"Citation": "Veeresham C. Natural products derived from plants as a source of drugs. J Adv Pharm Technol Res. 2012;3:200\u2013201. doi: 10.4103/2231-4040.104709.", "ArticleIdList": ["10.4103/2231-4040.104709", "PMC3560124", "23378939"]}, {"Citation": "Cowan M.M. Plant products as antimicrobial agents. Clin Microbiol Rev. 1999;12(4):564\u2013582.", "ArticleIdList": ["PMC88925", "10515903"]}, {"Citation": "Kirimuhuzya C., Waako P., Joloba M., Odyek O. The anti-mycobacterial activity of Lantana camara a plant traditionally used to treat symptoms of tuberculosis in South-western Uganda. Afr Health Sci. 2009;9:40\u201345. doi: 10.4314/ahs.v9i1.7101.", "ArticleIdList": ["10.4314/ahs.v9i1.7101", "PMC2932521", "20842241"]}, {"Citation": "Kirimuhuzya C., Bunalema L., Waako P., Tabuti J.R.S., Orodho J., Magadula J.J., et al. Efficacy of Cryptolepis sanguinolenta root extract on slow-growing rifampicin resistant Mycobacterium tuberculosis. J Med Plants Res. 2012;6:1140\u20131146. doi: 10.5897/JMPR10.856.", "ArticleIdList": ["10.5897/JMPR10.856"]}, {"Citation": "J. A.O., P. O., J. B.T., N. O., J.j M., C. K. Indigenous knowledge of communities around Lake Victoria Basin regarding treatment and management of tuberculosis using medicinal plants. Int J Med. Med Sci. 2014;6(1):16\u201323. doi: 10.5897/IJMMS09.374.", "ArticleIdList": ["10.5897/IJMMS09.374"]}, {"Citation": "Bunalema L., Fotso G.W., Waako P., Tabuti J., Yeboah S.O. Potential of Zanthoxylum leprieurii as a source of active compounds against drug resistant Mycobacterium tuberculosis. BMC Complement Altern Med. 2017;17:4\u20139. doi: 10.1186/s12906-017-1602-x.", "ArticleIdList": ["10.1186/s12906-017-1602-x", "PMC5289037", "28148252"]}, {"Citation": "Kumar A., Chettiar S., Parish T. Current challenges in drug discovery for tuberculosis. Expert Opin Drug Discov. 2017;12(1):1\u20134. doi: 10.1080/17460441.2017.1255604.", "ArticleIdList": ["10.1080/17460441.2017.1255604", "27797593"]}, {"Citation": "Mohan A., Padiadpu J., Baloni P., Chandra N. Complete Genome Sequences of a Mycobacterium smegmatis Laboratory Strain (MC2 155) and Isoniazid-Resistant (4XR1/R2) Mutant Strains. Genome Announc. 2015;3:4\u20135. doi: 10.1128/genomeA.01520-14.Copyright.", "ArticleIdList": ["10.1128/genomeA.01520-14.Copyright", "PMC4319614", "25657281"]}, {"Citation": "Hentschel J., Burnside C., Mignot I., Leibundgut M., Boehringer D., Ban N. The Complete Structure of the Mycobacterium The Complete Structure of the Mycobacterium smegmatis 70S Ribosome. Cell Reports. 2017;20(1):149\u2013160. doi: 10.1016/j.celrep.2017.06.029.", "ArticleIdList": ["10.1016/j.celrep.2017.06.029", "28683309"]}, {"Citation": "Chaturvedi V., Dwivedi N., Tripathi R.P., Sinha S. Evaluation of Mycobacterium smegmatis as a possible surrogate screen for selecting molecules active against multi-drug resistant Mycobacterium tuberculosis. Evaluation of Mycobacterium smegmatis as a possible surrogate screen for selecting molecules active against multi-drug resistant Mycobacterium tuberculosis. 2007;53(6):333\u2013337. doi: 10.2323/jgam.53.333.", "ArticleIdList": ["10.2323/jgam.53.333", "18187888"]}, {"Citation": "Andreu N., Soto C.Y., Roca I., Mart\u00edn C., Gibert I. Mycobacterium smegmatis displays the Mycobacterium tuberculosis virulence-related neutral red character when expressing the Rv0577 gene. FEMS Microbiol Lett. 2004;231:283\u2013289. doi: 10.1016/S0378-1097(04)00008-4.", "ArticleIdList": ["10.1016/S0378-1097(04)00008-4", "14987776"]}, {"Citation": "Barczak A., Domenech P., Boshoff H.M., Reed M., Manca C., Kaplan G., et al. In Vivo Phenotypic Dominance in Mouse Mixed Infections with Mycobacterium tuberculosis Clinical Isolates. J Infect Dis. 2005;192(4):600\u2013606. doi: 10.1086/432006.", "ArticleIdList": ["10.1086/432006", "16028128"]}, {"Citation": "Nguta J.M., Appiah-Opong R., Nyarko A.K., Yeboah-Manu D., Addo P.G.A. Current perspectives in drug discovery against tuberculosis from natural products. Int J Mycobacteriology. 2015;4(3):165\u2013183. doi: 10.1016/j.ijmyco.2015.05.004.", "ArticleIdList": ["10.1016/j.ijmyco.2015.05.004", "27649863"]}, {"Citation": "Falzon D., Jaramillo E., Schunemann H.J., Arentz M., Bauer M., Bayona J., et al. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J. 2011;38(3):516\u2013528. doi: 10.1183/09031936.00073611.", "ArticleIdList": ["10.1183/09031936.00073611", "21828024"]}, {"Citation": "Arthur P.K., Amarh V., Cramer P., Arkaifie G.B., Blessie E.J.S., Fuseini M.-S., et al. Characterization of Two New Multidrug-Resistant Strains of Mycobacterium smegmatis: Tools for Routine In Vitro Screening of Novel Anti-Mycobacterial Agents. Antibiot (Basel, Switzerland) 2019;8(1):4. doi: 10.3390/antibiotics8010004.", "ArticleIdList": ["10.3390/antibiotics8010004", "PMC6466533", "30609766"]}, {"Citation": "Palomino J.-C., Martin A., Camacho M., Guerra H., Swings J., Portaels Francoise. Resazurin microtiter assay plate: Simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2002;46(8):2720\u20132722. doi: 10.1128/AAC.46.8.2720-2722.2002.", "ArticleIdList": ["10.1128/AAC.46.8.2720-2722.2002", "PMC127336", "12121966"]}, {"Citation": "Hillemann D., Richter E., Rusch-Gerdes S. Use of the BACTEC mycobacteria growth indicator tube 960 automated system for recovery of mycobacteria from 9,558 extrapulmonary specimens, including urine samples. J Clin Microbiol. 2006;44(11):4014\u20134017. doi: 10.1128/JCM.00829-06.", "ArticleIdList": ["10.1128/JCM.00829-06", "PMC1698359", "17005737"]}, {"Citation": "Andersen P., Askgaard D., Ljungqvist L., Bennedsen J., Heron I. Proteins released from Mycobacterium tuberculosis during growth. Infect Immun. 1991;59(6):1905\u20131910.", "ArticleIdList": ["PMC257941", "1903768"]}, {"Citation": "Woods G.L., Brown-Elliott B.A., Conville P.S., et al. 3rd ed. Clinical and Laboratory Standards Institute; March; Wayne (PA): 2018. Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes.", "ArticleIdList": ["31339680"]}, {"Citation": "Patil U.S., Deshmukh O.S. Preliminary phytochemical screening of six medicinal plants used as traditional medicine. Int J Pharma Bio Sci. 2016;7:77\u201381."}, {"Citation": "M.A. Hossain K.A.S. AL-Raqmi Z.H. AL-Mijizy A.M. Weli Q. Al-Riyami Study of total phenol, flavonoids contents and phytochemical screening of various leaves crude extracts of locally grown Thymus vulgaris. Asian Pac J Trop Biomed 3 9 2013 705 710 10.1016/S2221-1691(13)60142-2.", "ArticleIdList": ["PMC3757278", "23998010"]}, {"Citation": "Tuyiringire N., Deyno S., Weisheit A., Tolo C.U., Tusubira D., Munyampundu J.-P., et al. Three promising antimycobacterial medicinal plants reviewed as potential sources of drug hit candidates against multidrug-resistant tuberculosis. Tuberculosis. 2020;124:101987. doi: 10.1016/j.tube.2020.101987.", "ArticleIdList": ["10.1016/j.tube.2020.101987", "32841928"]}, {"Citation": "Antimycobacterial M.A. Mbarara University of Science and Technology; 2019. Activity of Alkaloids from Medicinal Plants."}, {"Citation": "Sieniawska E., Sawicki R., Golus J., Georgiev M.I. Untargetted metabolomic exploration of the mycobacterium tuberculosis stress response to cinnamon essential oil. Biomolecules. 2020;10:357. doi: 10.3390/biom10030357.", "ArticleIdList": ["10.3390/biom10030357", "PMC7175327", "32111061"]}, {"Citation": "Tuyiringire N., Tusubira D., Munyampundu J.-P., Tolo C.U., Muvunyi C.M., Ogwang P.E. Application of metabolomics to drug discovery and understanding the mechanisms of action of medicinal plants with anti-tuberculosis activity. Clin Transl Med. 2018;7:29. doi: 10.1186/s40169-018-0208-3.", "ArticleIdList": ["10.1186/s40169-018-0208-3", "PMC6165828", "30270413"]}, {"Citation": "Vogwill T., MacLean R.C. The genetic basis of the fitness costs of antimicrobial resistance: A meta-analysis approach. Evol Appl. 2015;8(3):284\u2013295. doi: 10.1111/eva.12202.", "ArticleIdList": ["10.1111/eva.12202", "PMC4380922", "25861386"]}, {"Citation": "Gagneux S., Long C.D., Small P.M., Van T., Schoolnik G.K., Bohannan B.J.M. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science (80-) 2006;312(5782):1944\u20131946.", "ArticleIdList": ["16809538"]}, {"Citation": "Namouchi A., Cimino M., Favre-Rochex S., Charles P., Gicquel B. Phenotypic and genomic comparison of Mycobacterium aurum and surrogate model species to Mycobacterium tuberculosis: implications for drug discovery. BMC Genomics. 2017;18:530. doi: 10.1186/s12864-017-3924-y.", "ArticleIdList": ["10.1186/s12864-017-3924-y", "PMC5508667", "28705154"]}, {"Citation": "Lelovic N., Mitachi K., Yang J., Lemieux M.R., Ji Y., Kurosu M. Application of Mycobacterium smegmatis as a surrogate to evaluate drug leads against Mycobacterium tuberculosis Application of Mycobacterium smegmatis as a surrogate to evaluate drug leads against Mycobacterium tuberculosis. J Antibiot (Tokyo) 2020;73(11):780\u2013789. doi: 10.1038/s41429-020-0320-7.", "ArticleIdList": ["10.1038/s41429-020-0320-7", "PMC7554168", "32472054"]}, {"Citation": "Long Q., Zhou Q.i., Ji L., Wu J., Wang W., Xie J. Mycobacterium smegmatis genomic characteristics associated with its saprophyte lifestyle. J Cell Biochem. 2012;113(10):3051\u20133055. doi: 10.1002/jcb.24199.", "ArticleIdList": ["10.1002/jcb.24199", "22628184"]}, {"Citation": "Garc\u00eda M.T., Carre\u00f1o D., Tirado-V\u00e9lez J.M., Ferr\u00e1ndiz M.J., Rodrigues L., Gracia B., et al. Boldine-Derived Alkaloids Inhibit the Activity of DNA Topoisomerase I and Growth of Mycobacterium tuberculosis. Front Microbiol. 2018;9 doi: 10.3389/fmicb.2018.01659.", "ArticleIdList": ["10.3389/fmicb.2018.01659", "PMC6066988", "30087665"]}, {"Citation": "Xie Y., Yang W., Tang F., Chen X., Ren L. Antibacterial activities of flavonoids: structure-activity relationship and mechanism. Curr Med Chem. 2015;22:132\u2013149. doi: 10.2174/0929867321666140916113443.", "ArticleIdList": ["10.2174/0929867321666140916113443", "25245513"]}, {"Citation": "Bouarab-Chibane L., Forquet V., Lant\u00e9ri P., Cl\u00e9ment Y., L\u00e9onard-Akkari L., Oulahal N., et al. Antibacterial Properties of Polyphenols: Characterization and QSAR (Quantitative Structure-Activity Relationship) Models. Front Microbiol. 2019;10 doi: 10.3389/fmicb.2019.00829.", "ArticleIdList": ["10.3389/fmicb.2019.00829", "PMC6482321", "31057527"]}, {"Citation": "Guimar\u00e3es A.C., Meireles L.M., Lemos M.F., Guimar\u00e3es M.C.C., Endringer D.C., Fronza M., et al. Antibacterial Activity of Terpenes and Terpenoids Present in Essential Oils. Molecules. 2019;24(13):2471. doi: 10.3390/molecules24132471.", "ArticleIdList": ["10.3390/molecules24132471", "PMC6651100", "31284397"]}, {"Citation": "Barbosa A.D.P. AN OVERVIEW ON THE BIOLOGICAL AND PHARMACOLOGICAL ACTIVITIES OF SAPONINS. Int J Pharm Pharm Sci. 2014;6:47\u201350."}, {"Citation": "Mandal P., Sinha Babu S.P., Mandal N.C. Antimicrobial activity of saponins from Acacia auriculiformis. Fitoterapia. 2005;76:462\u2013465. doi: 10.1016/j.fitote.2005.03.004.", "ArticleIdList": ["10.1016/j.fitote.2005.03.004", "15951137"]}, {"Citation": "Farha A.K., Yang Q.-Q., Kim G., Li H.-B., Zhu F., Liu H.-Y., et al. Tannins as an alternative to antibiotics. Food Biosci. 2020;38:100751. doi: 10.1016/j.fbio.2020.100751.", "ArticleIdList": ["10.1016/j.fbio.2020.100751"]}, {"Citation": "Scalbert A. Antimicrobial properties of tannins. Phytochemistry. 1991;30:3875\u20133883. doi: 10.1016/0031-9422(91)83426-L.", "ArticleIdList": ["10.1016/0031-9422(91)83426-L"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "3", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "3", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "3", "Day": "15", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "3", "Day": "3"}], "PublicationStatus": "epublish", "ArticleIdList": ["35284659", "PMC8904236", "10.1016/j.jctube.2022.100307", "S2405-5794(22)00012-2"]}}], "PubmedBookArticle": []}